Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease

The JAK-STAT signalling system utilised by many cytokines and growth factors has recently been exploited to develop a range of new therapies for chronic inflammatory disease, autoimmune conditions, and cancers. However, there have been several limitations, emphasising the need for more therapeutic options